spacer
home > ict > autumn 2017 > helping hands
PUBLICATIONS
International Clinical Trials

Helping Hands

To be able to discuss how site nursing support benefits
the clinical trial industry and home care in particular, the
ongoing obstacles need to be understood. Clinical trial sites
face many challenges, such as engaging minority groups
efficiently and quickly identifying patients, while coping
with increased work load due to the small pool of available
research locations.

Equal Representation

One barrier that continues to impact clinical trials is the
enrolment of ethnic minority groups. These classes remain
underrepresented in treatment experiments that could
save their lives. However, some diseases are more prevalent
in different racial and ethnic groups – African Americans
are approximately 70% more likely to be diagnosed with
diabetes, for example (1). Therefore, to produce a drug
that will best treat these patients they must be included
in clinical trials.

This remains an obstacle for several reasons: a lack of
minority principal investigators (PI), a lack of awareness
of clinical trials among these groups or patients living too
far from an enrolling location.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Helena Baker is Vice President of Nursing at Medical Research Network and has over 32 years’ experience in nursing and healthcare. She previously worked at the Royal London Hospital in Whitechapel, Ferring Pharmaceuticals Ltd and St Bartholomew’s Hospital in the UK, as well as acting as a healthcare analyst to the pharmaceutical industry.
spacer
Helena Baker
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

BioIVT Webinar Will Discuss How to Optimize Microbiome Research

BioIVT, a leading provider of research models and services for drug development, today announced that it is hosting a webinar entitled “The Microbiome: Understanding Why Collection and Processing Matters” at 11 a.m. ET on July 25.
More info >>

White Papers

Time lapse photography to demonstrate the potential antimicrobial abilities of Dycem contamination control flooring

Dycem

A defined volume of bioluminescent reporter bacteria was deposited onto 20 mm x 20 mm coupons of Dycem flooring, vinyl tile and ITW Alma tacky mat. Through monitoring of bacterial bioluminescence, metabolic inhibition was observed on all three surfaces however the effect occurred more rapidly on Dycem flooring than on vinyl or ITW Alma. Recovery counts after three hours of exposure to the floor surfaces showed between a 65% and 100% decrease in the number of viable organisms recovered from Dycem flooring compared to controls. On vinyl and ITW Alma flooring, there were slight increases in the number of viable survivors recovered compared to controls. Dycem flooring inhibited the metabolic activity and reduced the number of viable survivors recovered of Salmonella enterica Serovar Typhimurium DT104 pGLITE. It remains unclear as to whether this effect is attributable to the impregnated biocide or rapid drying of the inoculum on this surface.
More info >>

 
Industry Events

Outsourcing Clinical Trials Nordics 2018

30-31 October 2018, Copenhagen, Denmark

Following on from the success of the 2017 Outsourcing in Clinical Trials Nordics conference, Arena International is pleased to announce that the event will return for its 6th year in 2018. The 2018 event welcomes biopharmaceutical and medical device companies from across the Nordic region to share knowledge and challenges of outsourcing and clinical operations.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement